Navigation Links
Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C.
Date:9/27/2011

 

Infrared Imaging Systems, Inc. of Marysville, Ohio (www.irimagesys.com)   

InfraScan, Inc. of Philadelphia, Pennsylvania (www.infrascanner.com)  

INRange Systems, Inc. of Altoona, Pennsylvania (www.inrangesystems.com)  

Insituvue of Pittsburgh, Pennsylvania (www.insituvue.com

Interface Biologics, Inc. of Toronto, Canada (www.interfacebiologics.com)

Leap Medical of Montreal, Canada (www.leapmedical.ca)  

LifeBond Ltd of Israel, (www.life-bond.com)

Lumora of Cambridgeshire, United Kingdom (www.lumora.co.uk)   

MedApps of Scottsdale, Arizona (www.medapps.com)  

Medi-Code of Katy, TX (www.medi-code.com)

MedMira of Halifax, Nova Scotia (www.medmira.com)

MedVoxel of British Columbia, Canada (www.medvoxel.com)

Monteris Medical, Inc. of Winnipeg, Canada & Kalamazoo, Michigan (www.monteris.com)

NeuroWave Systems Inc. of Cleveland Heights, Ohio (www.neurowavesystems.com)   

Novascan, LLC of Milwaukee, Wisconsin (www.novascan.com)

OJ Bio of Newcastle, United Kingdom  (www.oj-bio.com)

Pacific Edge of Dunedin, New Zealand (www.pacificedge.co.nz)

Precision Medical Devices, Inc. of Fort Lau
'/>"/>

SOURCE AdvaMed 2011
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Update: OncoSec Announces Positive Results From Head & Neck and Breast Cancer Trials
2. UPDATE: Total Victory for Schering-Plough (Now Merck) Pharmaceutical Reps in National Suit for Overtime Pay
3. UPDATE: FDA Approves New Drug to Treat Chronic Obstructive Pulmonary Disease
4. Update: Clinical Trial Establishes Catheter-based Aortic Valve Replacement As New Standard of Care for Patients Who Cannot Undergo Surgery
5. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
6. Update: International HIV/AIDS Partnership Wins Two Awards for Supply Chain Excellence
7. UPDATE: FDA Issues 22 Warning Letters to Web site Operators
8. UPDATE: US Oncology Research Network Participates in Phase III Follow-up Study to BiPars Investigational Cancer Drug BSI-201
9. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
10. UPDATE: Infant Primates Given Vaccines on U.S. Childrens Immunization Schedule Develop Behavioral Symptoms of Autism
11. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... WAYNE, Pa. , July 31, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced the closing of its previously announced underwritten ... stock at a public offering price of $11.25 ... the offering included 1,000,000 shares issued upon the ...
(Date:7/31/2015)... , July 31, 2015 ... for video, data and cloud computing operators has ... leading pharma giant for Internet of Things (IoT) ... applications offered on subscription model.      ... giant is striving for business innovations to make ...
(Date:7/30/2015)... (NYSE: RMD ) today announced results for its ... was $453.1 million, a 9 percent increase compared with ... increase on a constant currency basis).  Net income was ... 2014.  Diluted earnings per share for the quarter were ... The results for the quarter ended ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 2ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 3ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 4ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 5ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 6ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 7ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 8ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 9ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 10ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 11ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 12ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 13ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 14ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 15ResMed Inc. Announces Results for the Fourth Quarter and Fiscal Year 2015 16
... SAN DIEGO, Oct. 18, 2011 Halozyme Therapeutics, ... company developing and commercializing products targeting the ... and drug delivery markets, today announced that the ... that women with HER2-positive early breast cancer who ...
... Oct. 17, 2011 Express Scripts (Nasdaq: ESRX ... North America, announced today its intention to release its third ... closes and will hold its quarterly conference call to discuss ... a.m. Eastern Time (8:30 a.m. Central Time). This ...
Cached Medicine Technology:Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 2Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 3Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial 4
(Date:8/1/2015)... , ... August 01, 2015 , ... The condition where ... both men and women often causing pain and discomfort. Those who spend a lot ... problem, and Northeast Houston Vein Center is doing what it can to create awareness ...
(Date:8/1/2015)... , ... August 01, 2015 , ... Brig and Lita ... are announcing the unification of their Healthy Home mission with the HOPE Movement of ... years, the founders of both companies have agreed to join their missions of purpose ...
(Date:8/1/2015)... Atlanta, GA (PRWEB) , ... August 01, 2015 , ... ... iPhone app that is free to download on the Apple AppStore. , The ... energy levels, even mood, thus acting as a tool to view personal health and ...
(Date:8/1/2015)... ... August 01, 2015 , ... On March 19, 2015 Phil Valentine – the Executive ... the Appalachian Trail by stepping off Springer Mountain and heading north. Since that ... 26th Phil reached Connecticut and was greeted by friends and family. He visited CCAR ...
(Date:7/31/2015)... ... July 31, 2015 , ... When the weather turned hot ... their new type of sod called Leisure Time(TM) zoysia . It's nicknamed LTZ(TM) ... To commemorate introduction of this new type of sod, Super-Sod is giving away red ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 2Health News:Northeast Houston Vein Center Warns Men about Varicose Veins 3Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Lume Wellness Launches Health and Fitness Tracker iPhone App 2Health News:Connecticut Executive Hikes Appalachian Trail to Raise Awareness About Recovery. 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2
... a study testing a vaginal microbicide with an antiretroviral (ARV) ... was significantly more protective against HIV infection than a placebo ... the study, known as CAPRISA 004, are to be reported ... published online by the journal Science . ...
... N.C. Monday, July 19, 2010 Kidney disease ... a million individuals in the United States requiring dialysis ... The problem is particularly acute among African-Americans, whose rates ... of European Americans. As reported online this month ...
... Cancer researchers have discovered a previously unknown type ... cells that may lead to better insight about environmental ... in the journal Genome Research by researchers ... James Cancer Hospital and Richard J. Solove Research Institute ...
... sex offenders are often stereotyped and treated as socially ... they are more likely to be characterized by atypical ... coercive sex with peers and adults, and exposing their ... likely to have a history of sexual abuse themselves, ...
... HealthDay Reporter , MONDAY, July 19 (HealthDay ... illicit "club drug" Ecstasy may have one positive use: ... disorder (PTSD). The drug, also known by its ... standard treatments have failed. But experts stressed that ...
... July 2010 [Vienna, Austria]Scientists, practitioners and advocates from around ... leaders to commit at least $US20 billion to the ... its upcoming replenishment meeting in October. Because the level ... Global Fund,s grant levels for 2011-2013, the meeting is ...
Cached Medicine News:Health News:Microbicide trial results a turning point for HIV prevention, says team testing same gel 2Health News:Microbicide trial results a turning point for HIV prevention, says team testing same gel 3Health News:Investigators identify gene associated with kidney disease in African-American population 2Health News:Investigators identify gene associated with kidney disease in African-American population 3Health News:Breast cancer cells regulate multiple genes in response to estrogen-like compounds 2Health News:New study challenges stereotypes of adolescent sex offenders 2Health News:New study challenges stereotypes of adolescent sex offenders 3Health News:Researchers Use Ecstasy to Treat PTSD 2Health News:Researchers Use Ecstasy to Treat PTSD 3Health News:AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access 2Health News:AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access 3Health News:AIDS 2010 delegates and speakers unite in support of full funding for the Global Fund, the next milestone in drive for universal access 4
Ergonomically designed, the Invacare Printing Pulse Oximeter provides fast, reliable spot-check information and documentation of SpO2 and pulse rate. It is ideal for all patients from neonate to adul...
The FetalSAT™ System with DualSens Sensor displays continuous, real-time fetal pulse oximetry (FSpO2) and fetal pulse rate (FPR) values in one compact monitor....
... The Invacare Digital Pulse ... and pulse strength. It is ... measurements on challenging patients. The ... other artifacts, informs the operator ...
The OX-2 is configured asstandalone or handheld unit, designed for hospital, transport and home use....
Medicine Products: